Navigation Links
Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
Date:6/10/2009

MADISON, N.J., June 10 /PRNewswire-FirstCall/ -- On Thursday, July 23, 2009, Wyeth (NYSE: WYE) will announce financial results for the 2009 second quarter. The Company will hold a conference call with research analysts at 8:00 a.m. Eastern Time on July 23, 2009.

Interested investors and others may listen to the call live or on a delayed basis through our Internet webcast, which may be accessed by visiting our website at www.wyeth.com and clicking on the "Investor Relations" icon.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others, risks related to our proposed merger with Pfizer, including satisfaction of the conditions of the proposed merger on the proposed timeframe or at all, contractual restrictions on the conduct of our business included in the merger agreement, and the potential for loss of key personnel, disruption in key business activities or any impact on our relationships with third parties as a result of the announcement of the proposed merger; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval an
'/>"/>

SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
2. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
3. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
4. Wyeth Announces Election of New Principal Corporate Officer
5. Wyeth Declares Preferred Stock Dividend
6. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
9. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
10. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
11. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Clinverse, Inc. , ... clinical trials, today announced it will be exhibiting ... #2000) in Boston, June 24-26, 2013. Clinverse’s ... only fully configurable, cloud-based clinical financial lifecycle system. ... within Clinverse’s eClinical Commerce Network, automates site contract ...
(Date:6/19/2013)... Md. , June 19, 2013 Synthetic Biologics, ... the prevention and treatment of serious infectious diseases, announced today ... 6 th Annual OneMedForum New York Conference on Thursday, ... New York City . Mr. Riley is scheduled to ... webcast of Synthetic Biologics, presentation can be accessed by logging ...
(Date:6/19/2013)... 2013 MO BIO Laboratories, Inc., the ... microbial nucleic acid purification, announces the launch of ... of pure protein from all soil types. This ... 20 th anniversary of the company and ... (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ) The ...
(Date:6/19/2013)... 2013  Continuing its long history of proven clinical ... Coulter , Inc. announces the U.S. Food and Drug ... troponin I assay for use on its Access 2 ... Beckman Coulter,s troponin I test for over ... proven performance to continue providing dependability to laboratories supporting ...
Breaking Biology Technology:Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2Synthetic Biologics to Present at OneMedForum New York 2013 2MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3
... (Nasdaq: DCTH ) today announced that Jonathan Lewis, M.D., ... the Company, effective December 2, 2008. Dr. Lewis advised the ... result of additional commitments to new leadership positions. , ... , Dr. Harold Koplewicz, Chairman of the ...
... Therapeutics S.A.,(Alternext: ALEHT), a drug and diagnostic discovery company, ... by the INPI (National Institute of,Industrial Property) during the ... "Since its inception, ... value of its intellectual property and in particular from ...
... 3 GlaxoSmithKline,(LSE/NYSE: GSK ) announced today that ... the previously announced tender offer to purchase all of,the outstanding ... GNLB ), for $1.30 per share in cash without interest ... It is a condition to the completion of ...
Cached Biology Technology:Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3
(Date:6/19/2013)... June 19, 2013 AT&T * ... upcoming launch of the ultimate workhorse among ruggedized ... As one of the most ruggedized phones equipped ... Terrain embodies toughened versatility and business-ready features.  Its ... keep workforces moving forward, while also keeping up ...
(Date:6/19/2013)... , June 19, 2013 MedNet Solutions ... clinical study management systems, is pleased to announce its ... held June 23-27 in Boston . ... a recognized leader in cloud-based eClinical solutions, has exhibited ... be showcasing iMedNet™ EDC , MedNet,s ...
(Date:6/19/2013)... June 19, 2013 A decade-long JDRF-funded study ... Helmholtz Zentrum Mnchen, Germany, is providing a deeper ... risk of developing type 1 diabetes (T1D), highlighting ... for the disease. The study, "Seroconversion to Multiple ... in Children," was published today in The ...
Breaking Biology News(10 mins):AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 3AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 4AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 5MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2New data on islet autoantibodies in young children defines early type 1 diabetes development 2
... In a new study suggesting pesticides may be associated ... University of California, Berkeley,s School of Public Health have found ... food crops is related to lower intelligence scores at ... increase in measures of organophosphates detected during a mother,s pregnancy ...
... A pulse oximetry training video produced by Rafael Ortega, ... of anesthesiology at Boston Medical Center (BMC) and professor ... and his colleagues is featured in this week,s ... training video, which is the fifth BMC-produced video to ...
... to air pollution early in life and when a woman ... and may be associated with premenopausal breast cancer later in ... The findings indicated that higher air pollution exposure at birth ... a protein important to the adhesion of cells, a function ...
Cached Biology News:Prenatal pesticide exposure tied to lower IQ in children 2Prenatal pesticide exposure tied to lower IQ in children 3Prenatal pesticide exposure tied to lower IQ in children 4Pulse oximetry training video by BMC anesthesiologist published in NEJM 2Air pollution exposure affects chances of developing premenopausal breast cancer 2
... nucleic acids ,The GC-RICH PCR System, ... a proofreading polymerase, powers through templates that ... other polymerases and other blends of polymerases. ... the unique GC-RICH Resolution Solution combine to ...
... synthetic peptide corresponding to the third cytoplasmic ... receptor, conjugated to KLH. The immunizing peptide ... mouse gene. Physical form: Solution in ... sodium azide. Titertest method: IHC (p). ...
Canine Chondrocytes (CnC) (500,000 cells)...
... Fluorescein 6-Fam, Hex, Tet Cy3, ... Fluorescein Tamra Black Hole Quenchers Molecular ... Tet Tamra, Joe 3 Dabcyl ... New York Double labelled probes are purified ...
Biology Products: